Published in Anal Biochem on February 01, 1984
Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology (2002) 4.67
Binding and factor XIIIa-mediated cross-linking of a 27-kilodalton fragment of fibronectin to Staphylococcus aureus. Science (1980) 3.68
Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J Infect Dis (1998) 3.61
A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly. J Bacteriol (1997) 3.25
Gentamicin-resistant menadione and hemin auxotrophic Staphylococcus aureus persist within cultured endothelial cells. J Infect Dis (1994) 2.91
Recovery of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis. Clin Infect Dis (1997) 2.82
Fibronectin binding to Staphylococcus aureus. J Biol Chem (1982) 2.54
Identification, cloning, and initial characterization of rot, a locus encoding a regulator of virulence factor expression in Staphylococcus aureus. J Bacteriol (2000) 2.52
Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers. HIV Med (2009) 2.48
Reduced adherence to traumatized rat heart valves by a low-fibronectin-binding mutant of Staphylococcus aureus. Infect Immun (1989) 2.36
A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis (1997) 2.05
Fibronectin mediates attachment of Staphylococcus aureus to human neutrophils. Blood (1982) 1.93
Phagocytosis of Staphylococcus aureus by cultured bovine aortic endothelial cells: model for postadherence events in endovascular infections. Infect Immun (1986) 1.93
Artifactual elevation of the serum creatinine in patients receiving flucytosine for cryptococcal meningitis. J Infect Dis (1989) 1.92
Use of adhesion-defective mutants of Staphylococcus aureus to define the role of specific plasma proteins in promoting bacterial adhesion to canine arteriovenous shunts. Infect Immun (1995) 1.85
Staphylocidal action of thrombin-induced platelet microbicidal protein is not solely dependent on transmembrane potential. Infect Immun (1996) 1.79
A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor. J Exp Med (1997) 1.70
Ingestion of Staphylococcus aureus by bovine endothelial cells results in time- and inoculum-dependent damage to endothelial cell monolayers. Infect Immun (1987) 1.55
Severe hepatotoxicity in a patient receiving both acetaminophen and zidovudine. Am J Med (1992) 1.50
Cytotoxic effects of ingested Staphylococcus aureus on bovine endothelial cells: role of S. aureus alpha-hemolysin. Microb Pathog (1988) 1.46
Phagocytosis of Francisella tularensis by Rhesus monkey peripheral leukocytes. Infect Immun (1975) 1.46
Fibronectin-induced agglutination of Staphylococcus aureus correlates with invasiveness. J Lab Clin Med (1984) 1.46
Decreased susceptibility to antibiotic killing of a stable small colony variant of Staphylococcus aureus in fluid phase and on fibronectin-coated surfaces. J Antimicrob Chemother (1997) 1.44
Staphylococcus aureus small colony variants are induced by the endothelial cell intracellular milieu. J Infect Dis (1996) 1.43
Pyelonephritis, rash, and progressive respiratory failure in a pregnant woman. Clin Infect Dis (1992) 1.42
Protection of mice against lethal endotoxemia by a lipid A precursor. Infect Immun (1986) 1.42
What is the relevance of antiretroviral therapy that does not include protease inhibitors? Clin Infect Dis (1998) 1.39
Bloodstream infections caused by small-colony variants of coagulase-negative staphylococci following pacemaker implantation. Clin Infect Dis (1999) 1.39
Coagulase-negative staphylococci. Pathogens have major role in nosocomial infections. Postgrad Med (2001) 1.38
Cutting edge: the nucleotide receptor P2X7 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide. J Immunol (2001) 1.37
Variations in institutional review board decisions for HIV quality of care studies: a potential source of study bias. J Acquir Immune Defic Syndr (2001) 1.36
Fibronectin is more active than fibrin or fibrinogen in promoting Staphylococcus aureus adherence to inserted intravascular catheters. J Infect Dis (1993) 1.34
Adhesion of Staphylococcus aureus to surface-bound platelets: role of fibrinogen/fibrin and platelet integrins. J Infect Dis (1993) 1.34
Endotoxin in vitro interactions with human neutrophils: depression of chemiluminescence, oxygen consumption, superoxide production, and killing. Infect Immun (1979) 1.32
Elicitation of peritoneal polymorphonuclear neutrophils from mice. J Immunol Methods (1982) 1.32
Staphylococcus aureus small colony variants, electron transport and persistent infections. Int J Antimicrob Agents (2000) 1.31
Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcome. Antimicrob Agents Chemother (1993) 1.26
Where does a Staphylococcus aureus vaccine stand? Clin Microbiol Infect (2014) 1.18
Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages. J Biol Chem (1998) 1.17
Effects of subinhibitory concentrations of antibiotics on Staphylococcus aureus interactions with fibronectin. J Antimicrob Chemother (1983) 1.16
Biological and clinical effects of intravenous tumor necrosis factor-alpha administered three times weekly. Cancer Res (1991) 1.16
Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium. J Biol Chem (1996) 1.12
Lipid X ameliorates pulmonary hypertension and protects sheep from death due to endotoxin. Infect Immun (1987) 1.09
Racial differences in care among hospitalized patients with Pneumocystis carinii pneumonia in Chicago, New York, Los Angeles, Miami, and Raleigh-Durham. Arch Intern Med (1995) 1.09
Phagolysosome formation by polymorphonuclear neutrophilic leukocytes after ingestion of Escherichia coli that express type 1 pili. J Infect Dis (1987) 1.09
Blastomycosis is a serious disease, but let's not raise fears without conclusive data. WMJ (2001) 1.07
Quantitative comparison of clumping factor- and coagulase-mediated Staphylococcus aureus adhesion to surface-bound fibrinogen under flow. Infect Immun (1995) 1.06
Role of fibronectin in human monocyte and macrophage bactericidal activity. Infect Immun (1985) 1.05
Improving pneumococcal vaccine rates. Nurse protocols versus clinical reminders. J Gen Intern Med (1999) 1.05
Role of host and bacterial factors in modulating staphylococcal adhesion to implanted polymer surfaces. J Biomater Appl (1990) 1.05
Subinhibitory concentrations of antibiotics alter fibronectin binding to Staphylococcus aureus. Antimicrob Agents Chemother (1983) 1.04
Toward an understanding of biomaterial infections: a complex interplay between the host and bacteria. J Lab Clin Med (2000) 1.04
Stimulation of human polymorphonuclear leukocyte oxidative metabolism by type 1 pili from Escherichia coli. Infect Immun (1987) 1.04
Immunoelectron microscopic localization of fibronectin in adherence of Staphylococcus aureus to cultured bovine endothelial cells. J Infect Dis (1989) 1.03
Pneumonia and bacteremia caused by a previously undescribed Moraxella-like bacterium. J Clin Microbiol (1982) 1.03
Hepatitis C patients' self-reported adherence to treatment with pegylated interferon and ribavirin. Aliment Pharmacol Ther (2008) 1.02
Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review. Clin Infect Dis (1994) 1.00
Host defences and the vaginal mucosa. A re-evaluation. Scand J Urol Nephrol Suppl (1984) 1.00
Activation and inhibition of Limulus amebocyte lysate coagulation by chemically defined substructures of lipid A. Infect Immun (1985) 1.00
Using the national registry of HIV-infected veterans in research: lessons for the development of disease registries. J Clin Epidemiol (2001) 0.99
A new preadmission staging system for predicting inpatient mortality from HIV-associated Pneumocystis carinii pneumonia in the early highly active antiretroviral therapy (HAART) era. Am J Respir Crit Care Med (2000) 0.99
Left ventricular assist device infection is associated with increased mortality but is not a contraindication to transplantation. Circulation (1997) 0.97
Delays in tuberculosis isolation and suspicion among persons hospitalized with HIV-related pneumonia. Chest (2000) 0.96
Genetic differences in oxygen toxicity are correlated with cytochrome P-450 inducibility. Proc Natl Acad Sci U S A (1985) 0.96
Comparison of mycobacterial lymphadenitis among persons infected with human immunodeficiency virus and seronegative controls. Clin Infect Dis (1992) 0.95
Immunostimulatory, but not antiendotoxin, activity of lipid X is due to small amounts of contaminating N,O-acylated disaccharide-1-phosphate: in vitro and in vivo reevaluation of the biological activity of synthetic lipid X. Infect Immun (1991) 0.95
Lipid X protects mice against fatal Escherichia coli infection. Infect Immun (1988) 0.95
Bacterial colonization of functionalized polyurethanes. Biomaterials (2000) 0.94
Novel animal model for studying the molecular mechanisms of bacterial adhesion to bone-implanted metallic devices: role of fibronectin in Staphylococcus aureus adhesion. J Orthop Res (1996) 0.92
A low-fibronectin-binding mutant of Staphylococcus aureus 879R4S has Tn918 inserted into its single fnb gene. Microbiology (1996) 0.91
Pulmonary pathophysiological changes in sheep caused by endotoxin precursor, lipid X. J Appl Physiol (1985) (1985) 0.90
HIV-related Pneumocystis carinii pneumonia in older patients hospitalized in the early HAART era. J Gen Intern Med (2001) 0.89
Staphylococcus aureus small colony variants: formation and clinical impact. Int J Clin Pract Suppl (2000) 0.89
Fungal prosthetic arthritis: presentation of two cases and review of the literature. Rev Infect Dis (1988) 0.88
Potential contributions of viral envelope and host genetic factors in a human immunodeficiency virus type 1-infected long-term survivor. J Virol (1998) 0.88
Evaluating quality indicators for patients with community-acquired pneumonia. Jt Comm J Qual Improv (2001) 0.88
Haemophilus parainfluenzae vertebral osteomyelitis. Am J Med Sci (1987) 0.87
In vitro study of antiviral activity of immune spleen cells in experimental Venezuelan equine encephalomyelitis infection in mice. J Immunol (1974) 0.86
Comparative study of lipopolysaccharide-, lipid IVa-, and lipid X-induced tumor necrosis factor production in murine macrophage-like cell lines. Adv Exp Med Biol (1990) 0.86
Atypical roentgenographic manifestations of Pneumocystis carinii pneumonia. Arch Intern Med (1992) 0.85
Quantitative comparison of shear-dependent Staphylococcus aureus adhesion to three polyurethane ionomer analogs with distinct surface properties. J Biomed Mater Res (1997) 0.83
Recombinant interferon-gamma preserves human granulocyte bactericidal and chemoluminescence activities. J Infect Dis (1993) 0.83
Candida parapsilosis prosthetic joint infection unresponsive to treatment with fluconazole. Clin Infect Dis (1995) 0.83
Reversible CD4+ T lymphocyte depletion in a patient who had disseminated histoplasmosis and who was not infected with human immunodeficiency virus. Clin Infect Dis (1995) 0.83
Pharmacodynamic evaluation of the activity of antibiotics against hemin- and menadione-dependent small-colony variants of Staphylococcus aureus in models of extracellular (broth) and intracellular (THP-1 monocytes) infections. Antimicrob Agents Chemother (2012) 0.83
Small colony variants of Staphylococci: a link to persistent infections. Berl Munch Tierarztl Wochenschr (2000) 0.82
Simple procedure for measuring neutrophil chemiluminescence. J Clin Microbiol (1981) 0.82
Effect of dose and method of administration of endotoxin on cell mediator release in neonatal calves. Am J Vet Res (1993) 0.82
Bacterial lipopolysaccharide-stimulated GTPase activity in RAW 264.7 macrophage membranes. Biochem J (1991) 0.81
Inefficient in vitro killing of virulent or nonvirulent Salmonella typhimurium by murine polymorphonuclear neutrophils. Can J Microbiol (1984) 0.81
Clinical and biologic effects of combination therapy with gamma-interferon and tumor necrosis factor. Cancer (1992) 0.81
Epidemiology of bacteremic urinary tract infections in chronically hospitalized elderly men. J Urol (1991) 0.81
Complications of corticosteroid therapy in patients with the acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Chest (1990) 0.80
Normalization of intracellular calcium: a sweet solution to neutrophil dysfunction in diabetes? Ann Intern Med (1995) 0.80
Elimination and tissue distribution of the monosaccharide lipid A precursor, lipid X, in mice and sheep. Antimicrob Agents Chemother (1988) 0.80
Effect of oral beta-carotene supplementation on plasma human immunodeficiency virus (HIV) RNA levels and CD4+ cell counts in HIV-infected patients. Clin Infect Dis (1998) 0.79
Bacterial adhesion to functionalized polyurethanes. J Biomater Sci Polym Ed (1999) 0.79
Staphylococcal pyomyositis in patients infected by the human immunodeficiency virus. Am J Med (1991) 0.79